<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-05-04T09:21:12Z</responseDate><request verb="GetRecord" identifier="oai:riubu.ubu.es:10259/9527" metadataPrefix="ese">https://riubu.ubu.es/oai/request</request><GetRecord><record><header><identifier>oai:riubu.ubu.es:10259/9527</identifier><datestamp>2024-09-05T00:05:20Z</datestamp><setSpec>com_10259_4862</setSpec><setSpec>com_10259_5086</setSpec><setSpec>com_10259_2604</setSpec><setSpec>col_10259_4863</setSpec></header><metadata><europeana:record xmlns:europeana="http://www.europeana.eu/schemas/ese/" xmlns:confman="org.dspace.core.ConfigurationManager" xmlns:doc="http://www.lyncode.com/xoai" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.europeana.eu/schemas/ese/ http://www.europeana.eu/schemas/ese/ESE-V3.4.xsd">
<dc:title>Subcellular Localizations of RIG-I, TRIM25, and MAVS Complexes</dc:title>
<dc:creator>Sánchez-Aparicio, M. T.</dc:creator>
<dc:creator>Ayllón Barasoain, Juan</dc:creator>
<dc:creator>Leo-Macias, A.</dc:creator>
<dc:creator>Wolff, T.</dc:creator>
<dc:creator>García Sastre, Adolfo</dc:creator>
<dc:subject>Inﬂuenza</dc:subject>
<dc:subject>Innate immunity</dc:subject>
<dc:subject>Microscopy</dc:subject>
<dc:subject>Pathogen recognition receptors</dc:subject>
<dc:subject>RIG-I</dc:subject>
<dc:subject>Virus</dc:subject>
<dc:subject>Medicina</dc:subject>
<dc:subject>Salud</dc:subject>
<dc:subject>Microbiología</dc:subject>
<dc:subject>Enfermedades infecciosas</dc:subject>
<dc:subject>Medicine</dc:subject>
<dc:subject>Health</dc:subject>
<dc:subject>Microbiology</dc:subject>
<dc:subject>Communicable diseases</dc:subject>
<dc:description>The retinoic acid-inducible gene 1 (RIG-I) signaling pathway is essential for the recognition of viruses and the initiation of host interferon (IFN)-mediated antiviral responses. Once activated, RIG-I interacts with polyubiquitin chains generated by TRIM25 and binds mitochondrial antiviral signaling protein (MAVS), leading to the production of type I IFN. We now show specific interactions among these key partners in the RLR pathway through the use of bimolecular fluorescence complementation (BiFC) and super-resolution microscopy. Dimers of RIG-I, TRIM25, and MAVS localize into different compartments. Upon activation, we show that TRIM25 is redistributed into cytoplasmic dots associated with stress granules, while RIG-I associates with TRIM25/stress granules and with mitochondrial MAVS. In addition, MAVS competes with TRIM25 for RIG-I binding, and this suggests that upon TRIM25-mediated activation of RIG-I, RIG-I moves away from TRIM25 to interact with MAVS at the mitochondria. For the first time, the distribution of these three proteins was analyzed at the same time in virus-infected cells. We also investigated how specific viral proteins modify some of the protein complexes in the pathway. The protease NS3/4A from hepatitis C virus redistributes the complexes RIG-I/MAVS and MAVS/MAVS but not RIG-I/TRIM25. In contrast, the influenza A virus NS1 protein interacts with RIG-I and TRIM25 in specific areas in the cell cytoplasm and inhibits the formation of TRIM25 homocomplexes but not the formation of RIG-I/TRIM25 heterocomplexes, preventing the formation of RIG-I/MAVS complexes. Thus, we have localized spatially in the cell different complexes formed between RIG-I, TRIM25, and MAVS, in the presence or absence of two viral IFN antagonistic proteins.</dc:description>
<dc:description>We thank Peter Lichter (Heidelberg, Germany) for the BiFC plasmids and LuisMartinez-Sobrido for the HA-NS3/4A plasmids. We also acknowledge the help of theMicroscopy Shared Resource Facility at the Icahn School of Medicine at Mount Sinai,supported with funding from an NIH Shared Instrumentation Grant (1S10RR024745-01A1).This study was partly supported by the Center for Research on Inﬂuenza Pathogen-esis, the National Institute of Allergy and Infectious Disease (NIAID)-funded Center ofExcellence for Inﬂuenza Research and Surveillance (contract HHSN272201400008C), andby NIAID grant U19AI117873 (to A.G.-S.).</dc:description>
<dc:date>2024-09-04T11:23:25Z</dc:date>
<dc:date>2024-09-04T11:23:25Z</dc:date>
<dc:date>2017-01</dc:date>
<dc:type>info:eu-repo/semantics/article</dc:type>
<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
<dc:identifier>0022-538X</dc:identifier>
<dc:identifier>http://hdl.handle.net/10259/9527</dc:identifier>
<dc:identifier>10.1128/jvi.01155-16</dc:identifier>
<dc:identifier>1098-5514</dc:identifier>
<dc:language>eng</dc:language>
<dc:relation>Journal of Virology. 2017, V. 91, n. 2, e01155-16</dc:relation>
<dc:relation>https://doi.org/10.1128/jvi.01155-16</dc:relation>
<dc:relation>info:eu-repo/grantAgreement/NIH//1S10RR024745-01A1/US/</dc:relation>
<dc:relation>info:eu-repo/grantAgreement/NIAID//HHSN272201400008C/US/</dc:relation>
<dc:relation>info:eu-repo/grantAgreement/NIAID//U19AI117873/US/</dc:relation>
<dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
<dc:format>application/pdf</dc:format>
<dc:publisher>American Society for Microbiology</dc:publisher>
<europeana:object>https://riubu.ubu.es/bitstream/10259/9527/3/Aparicio-jv_2017.pdf.jpg</europeana:object>
<europeana:provider>Hispana</europeana:provider>
<europeana:type>TEXT</europeana:type>
<europeana:rights>http://rightsstatements.org/vocab/CNE/1.0/</europeana:rights>
<europeana:dataProvider>RIUBU. Repositorio Institucional de la Universidad de Burgos</europeana:dataProvider>
<europeana:isShownAt>http://hdl.handle.net/10259/9527</europeana:isShownAt>
</europeana:record></metadata></record></GetRecord></OAI-PMH>